{
  "turn_global_index": 379,
  "session_index": 36,
  "session_id": "ultrachat_290148",
  "turn_in_session": 11,
  "date": "2023/05/27 (Sat) 14:34",
  "role": "assistant",
  "content": "Yes, there are several types of immunotherapy drugs that have shown success in treating lung cancer. Here is a brief overview of these drugs and how they work in treating lung cancer.\n\n1. Checkpoint inhibitors: This is the most common type of immunotherapy used in lung cancer treatment. These drugs release the brakes on the immune system, allowing T-cells to attack cancer cells. Checkpoint inhibitors target specific proteins called PD-L1, PD-1 and CTLA-4 that are found on cancer cells or T cells to help them recognize and attack cancer cells. Examples of these drugs include pembrolizumab, nivolumab, durvalumab, and atezolizumab.\n\n2. Adoptive T-cell transfer: This is a type of immunotherapy where T cells are collected from the patient's blood, grown in the laboratory, and then infused back into the patient's body. This treatment helps boost the ability of the immune system to recognize and attack cancer cells more effectively.\n\n3. Monoclonal antibodies: These drugs are designed to recognize and target specific proteins on cancer cells, such as blood vessels or growth factors in the tumours. They can also force the immune system to attack cancer cells by signaling immune cells to destroy them. An example of this is bevacizumab.\n\n4. Oncolytic virus therapy: This is a type of immunotherapy that uses genetically modified viruses to attack cancer cells. The viruses are designed to infect and kill tumor cells while leaving healthy cells intact.\n\n5. CAR T-cell therapy: This is a type of immunotherapy that has been primarily used in blood cancers but is now being tested in lung cancer. It involves genetically modifying T cells taken from the patient and then infusing these cells back into the patient's body to target cancer cells.\n\nIt is important to keep in mind that these drugs work in different ways and have varying success rates depending on the patient's specific case. Your healthcare provider will help determine which type of immunotherapy is the best option for you based on individual factors such as the stage of the cancer, overall health, and genetic mutations in the tumor cells.",
  "has_answer": false
}